Literature DB >> 27488612

The new Asian modified CKD-EPI equation leads to more accurate GFR estimation in Chinese patients with CKD.

Jinghua Wang1, Peng Xie2, Jian-Min Huang3, Yan Qu4, Fang Zhang3, Ling-Ge Wei3, Peng Fu3, Xiao-Jie Huang3.   

Abstract

OBJECTIVE: To verify whether the new Asian modified CKD-EPI equation improved the performance of original one in determining GFR in Chinese patients with CKD.
METHOD: A well-designed paired cohort was set up. Measured GFR (mGFR) was the result of 99mTc-diethylene triamine pentaacetic acid (99mTc-DTPA) dual plasma sample clearance method. The estimated GFR (eGFR) was the result of the CKD-EPI equation (eGFR1) and the new Asian modified CKD-EPI equation (eGFR2). The comparisons were performed to evaluate the superiority of the eGFR2 in bias, accuracy, precision, concordance correlation coefficient and the slope of regression equation and measure agreement.
RESULTS: A total of 195 patients were enrolled and analyzed. The new Asian modified CKD-EPI equation improved the performance of the original one in bias and accuracy. However, nearly identical performance was observed in the respect of precision, concordance correlation coefficient, slope of eGFR against mGFR and 95 % limit of agreement. In the subgroup of GFR < 60 mL min-1/1.73 m2, the bias of eGFR1 was less than eGFR2 but they have comparable precision and accuracy. In the subgroup of GFR > 60 mL min-1/1.73 m2, eGFR2 performed better than eGFR1 in terms of bias and accuracy.
CONCLUSION: The new Asian modified CKD-EPI equation can lead to more accurate GFR estimation in Chinese patients with CKD in general practice, especially in the higher GFR group.

Entities:  

Keywords:  CKD-EPI equation; Chronic kidney disease; Glomerular filtration rate

Mesh:

Substances:

Year:  2016        PMID: 27488612     DOI: 10.1007/s11255-016-1386-9

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  28 in total

1.  ACP Journal Club: the CKD-EPI equation for eGFR predicted adverse outcomes after PCI better than other equations.

Authors:  Sean A Hebert; Donald A Molony
Journal:  Ann Intern Med       Date:  2015-11-17       Impact factor: 25.391

Review 2.  Chronic kidney disease.

Authors:  Andrew S Levey; Josef Coresh
Journal:  Lancet       Date:  2011-08-15       Impact factor: 79.321

3.  Evaluation of serum creatinine- and cystatin C-based equations for the estimation of glomerular filtration rate in a Chinese population.

Authors:  Xiao-Hua Pei; Juan He; Qiao Liu; Bei Zhu; Li-Hua Bao; Chen-Jing Yan; Jian-Qing Wu; Wei-Hong Zhao
Journal:  Scand J Urol Nephrol       Date:  2012-03-01

4.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

5.  Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults.

Authors:  G B Haycock; G J Schwartz; D H Wisotsky
Journal:  J Pediatr       Date:  1978-07       Impact factor: 4.406

6.  Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes.

Authors:  A S Levey; R Atkins; J Coresh; E P Cohen; A J Collins; K-U Eckardt; M E Nahas; B L Jaber; M Jadoul; A Levin; N R Powe; J Rossert; D C Wheeler; N Lameire; G Eknoyan
Journal:  Kidney Int       Date:  2007-06-13       Impact factor: 10.612

7.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

8.  CDK-EPI equation may be the most proper formula based on creatinine in determining glomerular filtration rate in Chinese patients with chronic kidney disease.

Authors:  Peng Xie; Jian-Min Huang; Hai-ying Lin; Wei-Jie Wu; Li-Ping Pan
Journal:  Int Urol Nephrol       Date:  2012-11-08       Impact factor: 2.370

9.  A new modified CKD-EPI equation for Chinese patients with type 2 diabetes.

Authors:  Xun Liu; Xiaoliang Gan; Jinxia Chen; Linsheng Lv; Ming Li; Tanqi Lou
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

10.  Estimation of Glomerular Filtration Rate Based on Serum Cystatin C versus Creatinine in a Uruguayan Population.

Authors:  Inés Lujambio; Mariana Sottolano; Leonella Luzardo; Sebastián Robaina; Nadia Krul; Lutgarde Thijs; Florencia Carusso; Alicia da Rosa; Ana Carina Ríos; Alicia Olascoaga; Mariela Garau; Liliana Gadola; Oscar Noboa; Jan A Staessen; José Boggia
Journal:  Int J Nephrol       Date:  2014-08-24
View more
  17 in total

1.  Measuring creatinine excretion and clearance for diagnosing and staging chronic kidney disease.

Authors:  Antonios H Tzamaloukas; Deepak Malhotra
Journal:  Int Urol Nephrol       Date:  2016-12-28       Impact factor: 2.370

2.  Elevated activating Fc gamma receptors levels correlated with susceptibility and severity of IgA nephropathy.

Authors:  Hongfen Li; Youxia Liu; Huyan Yu; Fanghao Wang; Junya Jia; Tiekun Yan; Shan Lin
Journal:  Ther Adv Chronic Dis       Date:  2022-06-27       Impact factor: 4.970

3.  Identification of endogenous 1-aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation.

Authors:  Hua Miao; Gang Cao; Xia-Qing Wu; Yuan-Yuan Chen; Dan-Qian Chen; Lin Chen; Nosratola D Vaziri; Ya-Long Feng; Wei Su; Yi Gao; Shougang Zhuang; Xiao-Yong Yu; Li Zhang; Yan Guo; Ying-Yong Zhao
Journal:  Br J Pharmacol       Date:  2020-05-28       Impact factor: 8.739

4.  Serum Levels of Joining Chain-Containing IgA1 Are Not Elevated in Patients with IgA Nephropathy.

Authors:  Guanhong Li; Xiaoyan Wang; Zhe Yang; Qing Zhao; Yubing Wen; Xuemei Li; Ruitong Gao
Journal:  Dis Markers       Date:  2019-07-02       Impact factor: 3.434

5.  Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan.

Authors:  Dan-Qian Chen; Gang Cao; Hua Chen; Christos P Argyopoulos; Hui Yu; Wei Su; Lin Chen; David C Samuels; Shougang Zhuang; George P Bayliss; Shilin Zhao; Xiao-Yong Yu; Nosratola D Vaziri; Ming Wang; Dan Liu; Jia-Rong Mao; Shi-Xing Ma; Jin Zhao; Yuan Zhang; You-Quan Shang; Huining Kang; Fei Ye; Xiao-Hong Cheng; Xiang-Ri Li; Li Zhang; Mei-Xia Meng; Yan Guo; Ying-Yong Zhao
Journal:  Nat Commun       Date:  2019-04-01       Impact factor: 14.919

6.  Methods and reporting of kidney function: a systematic review of studies from sub-Saharan Africa.

Authors:  June Fabian; Jaya A George; Harriet R Etheredge; Manuel van Deventer; Robert Kalyesubula; Alisha N Wade; Laurie A Tomlinson; Stephen Tollman; Saraladevi Naicker
Journal:  Clin Kidney J       Date:  2019-08-19

7.  Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.

Authors:  Youxia Liu; Hongfen Li; Huyan Yu; Fanghao Wang; Junya Jia; Tiekun Yan
Journal:  BMC Nephrol       Date:  2022-01-11       Impact factor: 2.388

Review 8.  Establishing the presence or absence of chronic kidney disease: Uses and limitations of formulas estimating the glomerular filtration rate.

Authors:  Ahmed Alaini; Deepak Malhotra; Helbert Rondon-Berrios; Christos P Argyropoulos; Zeid J Khitan; Dominic S C Raj; Mark Rohrscheib; Joseph I Shapiro; Antonios H Tzamaloukas
Journal:  World J Methodol       Date:  2017-09-26

9.  Expression correlation attenuates within and between key signaling pathways in chronic kidney disease.

Authors:  Hui Yu; Danqian Chen; Olufunmilola Oyebamiji; Ying-Yong Zhao; Yan Guo
Journal:  BMC Med Genomics       Date:  2020-09-21       Impact factor: 3.063

10.  Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy.

Authors:  Vera E Bukkems; Elise J Smolders; Gonzague Jourdain; David M Burger; Angela P Colbers; Tim R Cressey
Journal:  J Clin Pharmacol       Date:  2020-09-22       Impact factor: 3.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.